Entera Bio Ltd. named Gerald Lieberman as board chairman.

Lieberman was formerly the president and COO of AllianceBernstein LP, a privately owned investment manager, until 2009. Before that, he was with Sanford C. Bernstein & Co. Inc. as the senior vice president for finance and administration.

Israel-based Entera Bio develops and commercializes orally delivered treatments for orphan indications and other areas with significant unmet medical needs. The company is developing an oral formulation of the parathyroid hormone to treat hypoparathyroidism and osteoporosis.